Wesley Davis, from New York filed a stroke product liability lawsuit against Actavis and Watson. Davis alleged that the side effects of the testosterone patch AndroDerm caused him to suffer a serious stroke. Furthermore, Davis claimed that the drug manufacturers failed to warn men about the potential risks associated with use of testosterone replacement therapy (TRT).
AndroDerm patch is a low testosterone drug approved by the FDA in 1995 for treatment of low testosterone caused by a medical condition, called hypogonadism. The testosterone replacement therapy medication is delivered in permeable skin patches.